You are here

Eu Yan Sang Q2 net falls 31% on interest expense, taxes

But CEO Richard Eu points to strong operating profit growth

HIGHER interest costs and taxes caused traditional Chinese medicine (TCM) retailer Eu Yan Sang to post a 31 per cent decline in its net profit to $3.2 million for its second quarter ended Dec 31, 2013. Revenue, however, was up 18 per cent at $91.9 million due to its core retail business growing